The Federal Institute for Drugs and Medical Devices (BfArM) issues information on the conclusion of the graduated plan procedure ("Stufenplanverfahren") regarding the use of oral and rectal antiemetic agents containing dimenhydrinate/diphenhydramine in children under the age of three years.

To the risk assessment procedure (available in German only)